How has been the historical performance of Evexia Lifecare?

Answer:The historical performance of Evexia Lifecare shows significant fluctuations in key financial metrics over the years.

Breakdown:
Evexia Lifecare's net sales increased from 56.29 Cr in Mar'24 to 110.48 Cr in Mar'25, marking a substantial growth. However, net sales had previously declined from 69.55 Cr in Mar'23 to 56.29 Cr in Mar'24. The total operating income followed a similar trend, rising to 110.48 Cr in Mar'25 from 56.29 Cr in Mar'24, after a dip in the preceding years. The total expenditure, excluding depreciation, also increased to 106.40 Cr in Mar'25 from 54.31 Cr in Mar'24, reflecting higher costs associated with the increased sales. Operating profit (PBDIT) improved to 4.22 Cr in Mar'25 from 2.85 Cr in Mar'24, indicating better operational efficiency. Profit before tax showed a slight decrease to 1.44 Cr in Mar'25 from 1.93 Cr in Mar'24, while profit after tax also declined to 0.93 Cr in Mar'25 from 1.38 Cr in Mar'24. The company's total liabilities rose to 883.00 Cr in Mar'24 from 847.50 Cr in Mar'23, with long-term borrowings remaining significant at 676.64 Cr in Mar'24. Cash flow from operating activities improved to 17.00 Cr in Mar'24, contrasting with a negative cash flow in the previous year, while cash flow from investing activities saw a substantial outflow of -17.00 Cr in Mar'24. Overall, Evexia Lifecare's financial performance reflects a recovery in sales and operational profit, despite challenges in profitability and increasing liabilities.